These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25878187)

  • 1. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
    Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer.
    Song IH; Yeom SW; Heo S; Choi WS; Yang HC; Jheon S; Kim K; Cho S
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):262-7. PubMed ID: 23811122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Cho S; Yum S; Kim K; Jheon S
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):554-559. PubMed ID: 29490049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
    Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
    Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes for oligometastasis in resected non-small cell lung cancer.
    Shimada Y; Saji H; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):937-44. PubMed ID: 26207006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer.
    Kozu Y; Maniwa T; Takahashi S; Isaka M; Ohde Y; Nakajima T
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e53-8. PubMed ID: 23557919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with recurrence in patients with curatively resected stage I-II lung cancer.
    Koo HK; Jin SM; Lee CH; Lim HJ; Yim JJ; Kim YT; Yang SC; Yoo CG; Han SK; Kim JH; Shim YS; Kim YW
    Lung Cancer; 2011 Aug; 73(2):222-9. PubMed ID: 21168237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
    Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M
    Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.
    Hishida T; Yoshida J; Aokage K; Nagai K; Tsuboi M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):847-53. PubMed ID: 26201958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.